Ichor enters into an agreement with Pfizer to develop next generation TriGrid electroporation devices for use in Pfizer's vaccine-based immunotherapies for cancer indications SAN DIEGO--(BUSINESS WIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback